Elite Pharmaceuticals (ELTP) Current Deferred Revenue (2010 - 2025)
Elite Pharmaceuticals' Current Deferred Revenue came in at $2,222 for fiscal Q1 2026 (quarter ended Jun 30, 2025), down 83.3% from $13,333 a year earlier and down 60.0% from the prior quarter.
Elite Pharmaceuticals (ELTP) Current Deferred Revenue (2010 - 2025) Analysis & Trends
At the end of FY2025 (ended Mar 31, 2025), Elite Pharmaceuticals' Current Deferred Revenue was $5,556, down 58.3% from FY2024.
- Current Deferred Revenue carries a five-year compound annual growth rate of -50.1% (FY2020 to FY2025).
- Going back by fiscal year, Current Deferred Revenue was $13,333 in FY2024 (unchanged), $13,333 in FY2023 (unchanged), $13,333 in FY2022 (unchanged) and $13,333 in FY2021 (-92.6%).
- The fiscal Q1 2026 figure represents the lowest quarterly Current Deferred Revenue in data going back to fiscal Q2 2011.
- Year-over-year, Current Deferred Revenue has declined for four consecutive quarters, with an average decline of 22.9% over the last eight quarters.
- Across the past five years, year-over-year decline in Current Deferred Revenue ran from 0.0% in fiscal Q1 2025 to 98.0% in fiscal Q2 2021.
- Business Quant data shows ELTP's Current Deferred Revenue at $5,556 (Q4 2025), $8,889 (Q3 2025) and $12,222 (Q2 2025) in the three fiscal quarters before Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn |
| 10 | Elite Pharmaceuticals | 401.23 Mn | 274.64 Mn | 15.99 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 2,222.00 |
| Mar 31, 2025 | 5,556.00 |
| Dec 31, 2024 | 8,889.00 |
| Sep 30, 2024 | 12,222.00 |
| Jun 30, 2024 | 13,333.00 |
| Mar 31, 2024 | 13,333.00 |
| Dec 31, 2023 | 13,333.00 |
| Sep 30, 2023 | 13,333.00 |
| Jun 30, 2023 | 13,333.00 |
| Mar 31, 2023 | 13,333.00 |
| Dec 31, 2022 | 13,333.00 |
| Sep 30, 2022 | 13,333.00 |
| Jun 30, 2022 | 13,333.00 |
| Mar 31, 2022 | 13,333.00 |
| Dec 31, 2021 | 13,333.00 |
| Sep 30, 2021 | 13,333.00 |
| Jun 30, 2021 | 13,333.00 |
| Mar 31, 2021 | 13,333.00 |
| Dec 31, 2020 | 13,333.00 |
| Sep 30, 2020 | 13,333.00 |
Elite Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();